Health Experts: FDA Oversight Needs to be More Open and Transparent

The chairman of an outside committee of medical experts that advises the Food and Drug Administration on drug-safety issues said Friday the agency’s own drug-safety oversight board needed to be more open and transparent. The chairman of the committee recommended that the FDA add new members to its oversight board.